Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases.
Milena Fronza BroeringPedro Leonidas Oseliero FilhoPâmela Pacassa BorgesLuis Carlos Cides da SilvaMarcos Camargo KnirschLuana Filippi XavierPablo ScharfSilvana SandriMarco Antonio StephanoFernando Anselmo de OliveiraIbrahim M SayedLionel Fernel GamarraSoumita DasMárcia C A FantiniSandra H P FarskyPublished in: International journal of nanomedicine (2024)
Our findings demonstrate a simple and cost-effective approach to delivering Ac2-26 orally into the inflamed gut, highlighting its potential as non-invasive IBD therapy.